2021 Conference Chairmen

Caroll H. Neubauer, Executive Advisor, Water Street Healthcare Partners

Caroll Heinz Neubauer is a recently retired member of the global Management Board of the B. Braun Melsungen Group of Companies. Mr. Neubauer oversaw the North America operations from Bethlehem, PA, where he served as the Chairman and Chief Executive Officer of B. Braun of America Inc.

Mr. Neubauer served B. Braun for more than 30 years. In 1991, he was elected to the Management Board of B. Braun Melsungen AG and appointed General Counsel for the B. Braun group. Prior to that, he was the Head of the Legal, Security and Environmental Matters Departments for B. Braun Melsungen AG. Mr. Neubauer began his career with B. Braun in 1988 at B. Braun Melsungen AG, where he served as Legal Assistant to the Chairman of the Board and principal of the company.

Mr. Neubauer is, inter alia, since 2004 a Member of the Board of the German American Chamber of Commerce New York, from 2006 – 2019 as Chairman. He is a member of the Board of Directors of AdvaMed. He also serves as a member of the President’s Advisory Group of the U.S. Chamber of Commerce and Member of the Board of the Medical Device Innovation Consortium (MDIC).

Mr. Neubauer was born in New Jersey, and completed his schooling in both the United States and Germany. He earned a German Law Degree from The Albert Ludwigs University, Freiburg, Germany in 1983. Mr. Neubauer earned his Master of Laws (LL.M.) from Georgetown University in 1987.

John Liddicoat, MD, Executive Vice President and President, Americas Region, Medtronic

Dr. John Liddicoat was named Executive Vice President and President, Americas Region in September 2018, and serves as a member of the Medtronic Executive Committee.

Dr. Liddicoat joined Medtronic in 2006 as Vice President of Atrial Fibrillation Technologies. In December of 2006, John was named Vice President and General Manager of the Structural Heart Disease Business, which expanded his responsibilities to include the global operations of the surgical and transcatheter valve product portfolios. Soon thereafter, John assumed the leadership responsibilities of the entire Structural Heart business, and he was named the Senior Vice President and President of the Medtronic Structural Heart division. Under his leadership, the Structural Heart division doubled in revenue through a series of organic and acquisition activities.

Beginning in August 2014, Dr. Liddicoat served as Senior Vice President and President, Cardiac Rhythm and Heart Failure (CRHF) Division. In this role, he was responsible for the overall strategic direction and day-today global operations of five business units covering the diagnosis, treatment, and management of patients with cardiac dysrhythmias and heart failure with an annual revenue approaching $6B.

Dr. Liddicoat is a cardiothoracic surgeon who, prior to joining Medtronic, most recently practiced at the Beth Israel Deaconess Medical Center in Boston where he also held an appointment as Assistant Professor of Surgery at Harvard Medical School. John earned an MBA from Boston University, a doctor of medicine from the University of Chicago, and a bachelor’s degree from the University of Michigan. He completed his surgical training in general and cardiothoracic surgery at Johns Hopkins Hospital in Baltimore. Prior to joining Medtronic, Dr. Liddicoat founded two medical device companies, and served as a consultant to several venture capital firms and medical device companies.